Clear Search sequence regions
Bookmark Forward

QuickView for Paramethasone (compound)


PubChem
Name: Paramethasone
PubChem Compound ID: 5230728
Description: A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)
Molecular formula: C22H29FO5
Molecular weight: 392.461 g/mol
DrugBank
Identification
Name: Paramethasone
Name (isomeric): DB01384
Drug Type: small molecule
Description: A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)
Brand: Haldrone
Category: Glucocorticoids, Anti-inflammatory Agents
CAS number: 53-33-8
Pharmacology
Indication: For the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than hydrocortisone with supplementary fludrocortisone.
Pharmacology:
Paramethasone is a glucocorticoid with the general properties of corticosteroids. Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger a variety of important cardiovascular, metabolic, immunologic and homeostatic effects. Glucocorticoids are distinguished from mineralocorticoids ...
show more »
Mechanism of Action:
Glucocorticoids such as paramethasone can inhibit leukocyte infiltration at the site of inflammation, interfere with mediators of inflammatory response, and suppress humoral immune responses. The antiinflammatory actions of glucocorticoids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of po...
show more »
Protein binding: 80%
Biotransformation: Hepatic.
Route of elimination: Corticosteroids are metabolized primarily in the liver and are then excreted by the kidneys. Some of the topical corticosteroids and their metabolites are also excreted into the bile.
Toxicity: Side effects include inhibition of bone formation, suppression of calcium absorption delayed wound healing, immune suppression, and hyperglycemia.
Affected organisms: Humans and other mammals
Interactions
Drug interaction:
PhenobarbitalThe barbiturate, phenobarbital, may decrease the effect of the corticosteroid, paramethasone.
FosphenytoinThe enzyme inducer, fosphenytoin, may decrease the effect of the corticosteroid, paramethasone.
Acetylsalicylic acidThe corticosteroid, paramethasone, may decrease the effect of the salicylate, acetylsalicylic acid.
RifampinThe enzyme inducer, rifampin, may decrease the effect of the corticosteroid, paramethasone.
PyridostigmineThe corticosteroid, paramethasone, may decrease the effect of the anticholinesterase, pyridostigmine.
show more »

Targets


Enzymes


Carriers